Becker's Healthcare March 16, 2023
Noah Schwartz

The FDA has updated its guidance on using EHRs and electronic signatures in clinical trials to account for technological advances since the agency last updated its guidance in 2017, RegulatoryFocus reported March 15.

The updates provide recommendations for applying data integrity and data security tools to clinical trials.

The agency reiterated that sponsors and entities are responsible for ensuring that the records they submit through vendors comply with FDA regulations.

“In addition,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Clinical Trials, EMR / EHR, FDA, Govt Agencies, Health IT, Technology, Trends
Related Articles:
To Give Rare Disease Patients Hope, the FDA Must Re-Focus its Efforts
Opinion: Adding psychotherapy to drug therapy works, but the FDA may not be able to handle it
FDA clears heart rhythm AI that turns smartphones into medical devices
Why Millions Are Trying FDA-Authorized Alternatives to Big Pharma’s Weight Loss Drugs
Accelerated Approval Pathway for Cancer Drugs: Does It Work?

Share This Article